Filing metadata

Accession number
0001562180-22-004014
Form type
Form 4
Filer
Biohaven Pharmaceutical Holding Co Ltd.
CIK
CIK 1689813
Filed
May 12, 2022
Reporting period
May 10, 2022
Description
Insider transaction

Explore SEC Filings Hub